logo
Select company
Select metric
-1452.95%EBIT Margin
VS
Market
5
Sector
17
Industry
32
History
18
$ 42.97Close
$ 10.8 - $ 80.04 52-Week Range
Ticker Information

Ticker

KRRO

Company Name

KORRO BIO INC

Sector

Healthcare

Industry

Biotechnology

Exchange

NASDAQ

KORRO BIO INC - EBIT Margin Chart Analysis (TTM)

From
Zoom
1Y
3Y
5Y
10Y

KRRO - EBIT % Historical data
DateEarning Before Interest & Taxes (EBIT)EBIT MarginRevenues
6/30/2025$ -91.26M-1452.95%$ 6.28M
3/31/2025$ -87.29M-1810.56%$ 4.82M
12/31/2024$ -83.44M-3674.15%$ 2.27M
9/30/2024$ -100.53M0%$ 0
6/30/2024$ -91.59M0%$ 0
3/31/2024$ -80.93M0%$ 0
12/31/2023$ -81.14M0%$ 0
9/30/2023$ -60.46M0%$ 0
6/30/2023$ -68.05M0%$ 0
3/31/2023$ -78.42M0%$ 0
Previous (option currently disabled)
1 (current)
Next (option currently disabled)

Key Performance Insights, Last 5 Years

  • KORRO BIO INC's latest trailing twelve months (TTM) EBIT % stands at -74.4%.
  • Over the past 5 years, KORRO BIO INC's average EBIT % has been -919.26%.
  • The median EBIT % for KORRO BIO INC during this period was -452.01%
  • KORRO BIO INC reached its highest EBIT % over the past 5 years at -74.28%.
  • The lowest EBIT % recorded by KORRO BIO INC in the same timeframe -3674.15%

KORRO BIO INC's EBIT % vs. competitors

We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue

EBIT % Benchmarks
CompanyEBIT %
CRBU : CARIBOU BIOSCIENCES INC -2427.19%ACOG : ALPHA COGNITION INC -434.42%TCRX : TSCAN THERAPEUTICS INC -1920.2%TVRD : TVARDI THERAPEUTICS INC -210.4%OBIO : ORCHESTRA BIOMED HOLDINGS INC -2366.27%FATE : FATE THERAPEUTICS INC -2025.05%CRVO : CERVOMED INC -290.75%OVID : OVID THERAPEUTICS INC -574.02%CBUS : CIBUS INC -4975.71%ARMP : ARMATA PHARMACEUTICALS INC -287.4%

Definition of EBIT Margin

[Calculation] A company’s [EBIT] as a percentage of [Revenue]. Measures how much earnings a company produces for each dollar of revenue generated before interest and taxes.
EBIT / Revenues
(=) EBIT %
EBIT % for KORRO BIO INC is calculated as follows: EBIT [ $ -23.62M ] / Revenues [ $ 31.74M ]
(=) EBIT % [ -74.4% ]

KRRO - EBIT Margin, Last 5 years

-3674.15%

Minimum

Dec 31, 2024

-74.28%

Maximum

Dec 31, 2020

-919.26%

Average

-452.01%

Median

EBIT % Benchmark Analysis

The chart above depicts the distribution of EBIT % for companies in the Total Stock Market. The average EBIT % of the companies is 9.55% with a standard deviation of 23.96%.
The following table provides additional summary stats:
EBIT % in the Market:
filtered constituents3.26K
min-73.16%
max83.08%
average9.55%
median9.01%
std23.96%